Liver Cirrhosis and Portal Hypertension
Conditions
Interventions
Sponsors
Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Be at least 18 years of age; 2. Patients with cirrhosis or portal hypertension, scheduled for invasive HVPG measurement; 3. Be conscious and able to comply with study procedures; 4. Have read and signed the informed consent forms for participating in the study.
Exclusion criteria
Exclusion criteria: 1. Female patients who are pregnant or nursing; 2. Patients currently on chemotherapy or with other primary cancers requiring systemic or hepatic loco-regional treatment; 3. Patients who are medically unstable, terminally or seriously ill, or patients whose clinical course is unpredictable; 4. Patients with clinically unstable cardiac disease, for example: congenital heart defect, arrhythmia, uncontrolled heart failure (NYHA Class IV); 5. Patients with respiratory distress syndrome or clinically unstable pulmonary disease, for example: pulmonary hypertension, pulmonary emboli, pulmonary vasculitis, emphysema; 6. Patients with severe liver failure or hepatic encephalopathy (grade III-IV); 7. Patients with severe kidney failure; 8. Patients with severe coagulation disorders; 9. Patients with recent cerebral hemorrhage; 10. Patients with unstable occlusive disease or thrombosis within the hepatic, portal, or mesenteric veins; 11. Patients who are anaphylactic allergy to iodinated contrast.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Non-invasive Portal Pressure;HVPG; | — |
Countries
China
Contacts
Public ContactLuo Meng
Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine
Outcome results
None listed